Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dyfrig A Hughes

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
British Journal of Pharmacology|May 17, 2020
Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepamDyfrig A Hughes
Clinical Pharmacology and Therapeutics|February 14, 2018
Economics of Pharmacogenetic-Guided Treatments: Underwhelming or Overstated?Dyfrig A Hughes
British Journal of Clinical Pharmacology|April 4, 2008
Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimensDyfrig A Hughes
Pharmacoeconomics|March 5, 2026
Comment on "The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective"Dyfrig A Hughes
British Journal of Clinical Pharmacology|February 25, 2012
PharmacoeconomicsDyfrig A Hughes
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2007
Feasibility, validity and reliability of the Welsh version of the EQ-5D health status questionnaireDyfrig A Hughes
European Journal of Cancer (Oxford, England : 1990)|June 14, 2005
Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: pharmacoeconomic considerationsDyfrig A Hughes
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic impact of poor compliance with pharmaceuticalsDyfrig A Hughes
Clinical Pharmacology and Therapeutics|June 26, 2019
Medicines Shortages in the United KingdomDyfrig A Hughes
British Journal of Clinical Pharmacology|February 27, 2020
Medication adherence-Key considerations for clinical pharmacologistsDyfrig A Hughes
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
British Journal of Pharmacology|May 17, 2020
Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepamDyfrig A Hughes
Clinical Pharmacology and Therapeutics|February 14, 2018
Economics of Pharmacogenetic-Guided Treatments: Underwhelming or Overstated?Dyfrig A Hughes
British Journal of Clinical Pharmacology|April 4, 2008
Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimensDyfrig A Hughes
Pharmacoeconomics|March 5, 2026
Comment on "The Importance of Structured Expert Elicitation to Inform Outcomes Following Treatment Discontinuation: Evidence Assessment Group Perspective"Dyfrig A Hughes
British Journal of Clinical Pharmacology|February 25, 2012
PharmacoeconomicsDyfrig A Hughes
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2007
Feasibility, validity and reliability of the Welsh version of the EQ-5D health status questionnaireDyfrig A Hughes
European Journal of Cancer (Oxford, England : 1990)|June 14, 2005
Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: pharmacoeconomic considerationsDyfrig A Hughes
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Economic impact of poor compliance with pharmaceuticalsDyfrig A Hughes
Clinical Pharmacology and Therapeutics|June 26, 2019
Medicines Shortages in the United KingdomDyfrig A Hughes
British Journal of Clinical Pharmacology|February 27, 2020
Medication adherence-Key considerations for clinical pharmacologistsDyfrig A Hughes
Pageof 17